These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of prostacyclin inhibition by tranylcypromine on uterine 6-keto-pgf 1 alpha levels during estrogen hyperemia in rats. Farley DB; Van Orden DE Prostaglandins; 1982 May; 23(5):657-74. PubMed ID: 6750692 [TBL] [Abstract][Full Text] [Related]
4. The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs. Fletcher JR; Ramwell PW Circ Shock; 1980; 7(3):299-308. PubMed ID: 7004660 [TBL] [Abstract][Full Text] [Related]
5. The influence of prostacyclin on hemodynamic and coronary blood flow in dogs. Teesalu R; Kòrgevee A Biomed Biochim Acta; 1988; 47(10-11):S56-9. PubMed ID: 3073770 [TBL] [Abstract][Full Text] [Related]
6. Effect of the prostacyclin synthetase inhibitor tranylcypromine on uterine blood flow in pregnancy. Clark KE; Harrington DJ Prostaglandins; 1982 Feb; 23(2):227-36. PubMed ID: 7043656 [TBL] [Abstract][Full Text] [Related]
7. Decrease in cyclosporin-mediated prostacyclin production in renal versus carotid arteries: a mechanism for cyclosporin-induced hypertension. Hoover EL; Harrison BS; Williams WW; Tesi R; Adams CZ; Weaver WL; McMillen MA J Surg Res; 1990 May; 48(5):481-4. PubMed ID: 2112669 [TBL] [Abstract][Full Text] [Related]
8. Comparison in anesthetized dogs of the anti-aggregatory and hemodynamic effects of prostacyclin and a chemically stable prostacyclin analog, 6a-carba-PGI2 (carbacyclin). Aiken JW; Shebuski RJ Prostaglandins; 1980 Apr; 19(4):629-43. PubMed ID: 6992235 [TBL] [Abstract][Full Text] [Related]
9. Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin, PGI2. Kadowitz PJ; Chapnick BM; Feigen LP; Hyman AL; Nelson PK; Spannhake EW J Appl Physiol Respir Environ Exerc Physiol; 1978 Sep; 45(3):408-13. PubMed ID: 359514 [TBL] [Abstract][Full Text] [Related]
10. Myocardial Injury from Tranylcypromine-Induced Hypertensive Crisis Secondary to Excessive Tyramine Intake. Salter M; Kenney A Cardiovasc Toxicol; 2018 Dec; 18(6):583-586. PubMed ID: 30083815 [TBL] [Abstract][Full Text] [Related]
11. Is prostacyclin responsible for producing the hyperdynamic response during early sepsis? Wang P; Zhou M; Cioffi WG; Bland KI; Ba ZF; Chaudry IH Crit Care Med; 2000 May; 28(5):1534-9. PubMed ID: 10834708 [TBL] [Abstract][Full Text] [Related]
12. Systemic and pulmonary hypertension after abrupt cessation of prostacyclin: role of thromboxane A2. Cuiper LL; Price PV; Christman BW J Appl Physiol (1985); 1996 Jan; 80(1):191-7. PubMed ID: 8847301 [TBL] [Abstract][Full Text] [Related]
13. Systemic and coronary hemodynamic effects of prostacyclin and nitroprusside in conscious dogs. Dinerman J; Mehta JL; Nichols WW J Cardiovasc Pharmacol; 1988 Oct; 12(4):492-6. PubMed ID: 2465452 [TBL] [Abstract][Full Text] [Related]
14. Effects of tolazoline and prostacyclin on pulmonary hypertension in infants after cardiac surgery. Schranz D; Zepp F; Iversen S; Wippermann C; Huth R; Zimmer B; Jüngst BK; Oelert H Crit Care Med; 1992 Sep; 20(9):1243-9. PubMed ID: 1521438 [TBL] [Abstract][Full Text] [Related]
15. Tranylcypromine is not a selective inhibitor of prostacyclin in rats. Rajtar G; de Gaetano G Thromb Res; 1979 Jan; 14(1):245-8. PubMed ID: 371065 [No Abstract] [Full Text] [Related]
16. Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats. Blanco-Rivero J; Cachofeiro V; Lahera V; Aras-Lopez R; Márquez-Rodas I; Salaices M; Xavier FE; Ferrer M; Balfagón G Hypertension; 2005 Jul; 46(1):107-12. PubMed ID: 15956108 [TBL] [Abstract][Full Text] [Related]
17. Formation of prostacyclin (PGI2) by the ductus arteriosus of fetal lambs at different stages of gestation. Clyman RI; Mauray F; Koerper MA; Wiemer F; Heymann MA; Rudolph AM Prostaglandins; 1978 Oct; 16(4):633-42. PubMed ID: 364551 [TBL] [Abstract][Full Text] [Related]